175 related articles for article (PubMed ID: 19388049)
1. Rational redesign of neutral endopeptidase binding to merlin and moesin proteins.
Niv MY; Iida K; Zheng R; Horiguchi A; Shen R; Nanus DM
Protein Sci; 2009 May; 18(5):1042-50. PubMed ID: 19388049
[TBL] [Abstract][Full Text] [Related]
2. Direct binding of neutral endopeptidase 24.11 to ezrin/radixin/moesin (ERM) proteins competes with the interaction of CD44 with ERM proteins.
Iwase A; Shen R; Navarro D; Nanus DM
J Biol Chem; 2004 Mar; 279(12):11898-905. PubMed ID: 14704146
[TBL] [Abstract][Full Text] [Related]
3. Two Sides of the Coin: Ezrin/Radixin/Moesin and Merlin Control Membrane Structure and Contact Inhibition.
Michie KA; Bermeister A; Robertson NO; Goodchild SC; Curmi PMG
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018575
[TBL] [Abstract][Full Text] [Related]
4. Involvement of neutral endopeptidase in neoplastic progression.
Sumitomo M; Shen R; Nanus DM
Biochim Biophys Acta; 2005 Aug; 1751(1):52-9. PubMed ID: 16054017
[TBL] [Abstract][Full Text] [Related]
5. Neutral endopeptidase is a myristoylated protein.
Zheng R; Horiguchi A; Iida K; Lee J; Shen R; Goodman OB; Nanus DM
Mol Cell Biochem; 2010 Feb; 335(1-2):173-80. PubMed ID: 19756956
[TBL] [Abstract][Full Text] [Related]
6. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for type II membrane protein binding by ERM proteins revealed by the radixin-neutral endopeptidase 24.11 (NEP) complex.
Terawaki S; Kitano K; Hakoshima T
J Biol Chem; 2007 Jul; 282(27):19854-62. PubMed ID: 17459884
[TBL] [Abstract][Full Text] [Related]
8. The cytoplasmic tail of L-selectin interacts with members of the Ezrin-Radixin-Moesin (ERM) family of proteins: cell activation-dependent binding of Moesin but not Ezrin.
Ivetic A; Deka J; Ridley A; Ager A
J Biol Chem; 2002 Jan; 277(3):2321-9. PubMed ID: 11706008
[TBL] [Abstract][Full Text] [Related]
9. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
[TBL] [Abstract][Full Text] [Related]
10. Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor.
Yogesha SD; Sharff AJ; Giovannini M; Bricogne G; Izard T
Protein Sci; 2011 Dec; 20(12):2113-20. PubMed ID: 22012890
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.
Shimizu T; Seto A; Maita N; Hamada K; Tsukita S; Tsukita S; Hakoshima T
J Biol Chem; 2002 Mar; 277(12):10332-6. PubMed ID: 11756419
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of Short Linear Motif-Based Interactions of the FERM Domains of Ezrin, Radixin, Moesin, and Merlin.
Ali M; Khramushin A; Yadav VK; Schueler-Furman O; Ivarsson Y
Biochemistry; 2023 Jun; 62(11):1594-1607. PubMed ID: 37224425
[TBL] [Abstract][Full Text] [Related]
13. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
Surace EI; Haipek CA; Gutmann DH
Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
[TBL] [Abstract][Full Text] [Related]
14. Emergence and Evolution of ERM Proteins and Merlin in Metazoans.
Shabardina V; Kashima Y; Suzuki Y; Makalowski W
Genome Biol Evol; 2020 Jan; 12(1):3710-3724. PubMed ID: 31851361
[TBL] [Abstract][Full Text] [Related]
15. Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.
Maeda M; Matsui T; Imamura M; Tsukita S; Tsukita S
Oncogene; 1999 Aug; 18(34):4788-97. PubMed ID: 10490812
[TBL] [Abstract][Full Text] [Related]
16. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.
Shaw RJ; Paez JG; Curto M; Yaktine A; Pruitt WM; Saotome I; O'Bryan JP; Gupta V; Ratner N; Der CJ; Jacks T; McClatchey AI
Dev Cell; 2001 Jul; 1(1):63-72. PubMed ID: 11703924
[TBL] [Abstract][Full Text] [Related]
17. Moesin and merlin regulate urokinase receptor-dependent endothelial cell migration, adhesion and angiogenesis.
Degryse B; Britto M; Shan CX; Wallace RG; Rochfort KD; Cummins PM; Meade G; Murphy RP
Int J Biochem Cell Biol; 2017 Jul; 88():14-22. PubMed ID: 28473293
[TBL] [Abstract][Full Text] [Related]
18. The EBP50-moesin interaction involves a binding site regulated by direct masking on the FERM domain.
Finnerty CM; Chambers D; Ingraffea J; Faber HR; Karplus PA; Bretscher A
J Cell Sci; 2004 Mar; 117(Pt 8):1547-52. PubMed ID: 15020681
[TBL] [Abstract][Full Text] [Related]
19. Merlin differs from moesin in binding to F-actin and in its intra- and intermolecular interactions.
Huang L; Ichimaru E; Pestonjamasp K; Cui X; Nakamura H; Lo GY; Lin FI; Luna EJ; Furthmayr H
Biochem Biophys Res Commun; 1998 Jul; 248(3):548-53. PubMed ID: 9703963
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence resonance energy transfer analysis of merlin conformational changes.
Hennigan RF; Foster LA; Chaiken MF; Mani T; Gomes MM; Herr AB; Ip W
Mol Cell Biol; 2010 Jan; 30(1):54-67. PubMed ID: 19884346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]